HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacokinetics, distribution, and excretion of 125I-labeled human plasma-derived-FVIIa and -FX with MC710 (FVIIa/FX mixture) in rats.

AbstractINTRODUCTION:
MC710 is a mixture agent consisting of plasma-derived activated factor VII (FVIIa) and factor X (FX) at a weight ratio of 1:10 developed as a novel bypassing agent for the management of the bleeding of hemophilia patients with inhibitors. The pharmacokinetics, distribution, and excretion of (125)I-labeled-FVIIa ((125)I-FVIIa) and -FX ((125)I-FX) were studied in male rats after a single intravenous administration of (125)I-FVIIa or (125)I-FX combined with MC710.
METHODS:
(125)I-FVIIa or (125)I-FX was administered intravenously with MC710 to male rats in a single dosage (FVIIa 0.4 mg and FX 4 mg/kg body weight) and radioactivity and antigen levels in plasma were quantified for 24h. Urine and feces were sampled to study the excretion of radioactivity during 168 h after dosing. Whole-body autoradiography was performed to evaluate the qualitative distribution of radioactivity 168 h after dosing.
RESULTS AND CONCLUSIONS:
The half-life (t(1/2)α and t(1/2)β) of radioactivity and FVIIa antigen were 0.704 and 6.27 h, and 0.496 and 1.66 h, respectively and the area under the plasma concentration-time curve (AUC(0-∞)) of radioactivity and FVIIa antigen were 17,932 and 8671 ng·h/mL, respectively. The t(1/2) of radioactivity and FX antigen were 4.06 and 3.05 h, respectively, and the AUC(0-∞) of radioactivity and FX antigen were 320,143 and 395,794 ng·h/mL, respectively. About 80% of the administered dose of radioactivity was excreted in urine and feces by 168 h after administration. Tissue distribution experiments showed that FVIIa- and FX-related (125)I accumulated in bone and bone marrow, and disappeared slowly.
AuthorsYasushi Nakatomi, Manami Tsuji, Teruhisa Nakashima, Soutaro Gokudan, Hiroki Miyazaki, Kazuhiko Tomokiyo, Yoichi Ogata, Satomi Harano, Hajime Matsui, Takamichi Shigaki, Takahiro Nakamura, Masayuki Mogi
JournalThrombosis research (Thromb Res) Vol. 129 Issue 1 Pg. 62-7 (Jan 2012) ISSN: 1879-2472 [Electronic] United States
PMID21621824 (Publication Type: Journal Article)
CopyrightCopyright © 2011 Elsevier Ltd. All rights reserved.
Chemical References
  • Coagulants
  • Drug Combinations
  • Iodine Radioisotopes
  • MC710
  • Factor X
  • Factor VIIa
Topics
  • Animals
  • Area Under Curve
  • Bone Marrow (metabolism)
  • Bone and Bones (metabolism)
  • Coagulants (administration & dosage, blood, pharmacokinetics, urine)
  • Drug Combinations
  • Enzyme-Linked Immunosorbent Assay
  • Factor VIIa (administration & dosage, pharmacokinetics, pharmacology, urine)
  • Factor X (administration & dosage, pharmacokinetics, urine)
  • Feces (chemistry)
  • Half-Life
  • Humans
  • Injections, Intravenous
  • Iodine Radioisotopes
  • Male
  • Rats
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: